Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03193437
Title Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications

thymic carcinoma

thymoma

Therapies

Selinexor

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.